Remove Clinic Remove Events Remove Family Practice Remove Hospital
article thumbnail

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

Physician's Weekly

from Oslo University Hospital in Norway, and colleagues examined the efficacy and safety of FMT in primary CDI in a randomized, open-label, noninferiority trial. The researchers found that clinical cure and no disease recurrence within 60 days without additional treatment was observed in 66.7 Frederik Emil Juul, M.D., Additional C.

article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. For each diet, adverse events were infrequent.

article thumbnail

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

Physician's Weekly

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Mild-to-moderate gastrointestinal events were the most common adverse events with orforglipron. Julio Rosenstock, M.D.,